No Major Metabolic Alterations Accompany the Hypotensive Effect of Active Vitamin D: Results from three double-blind, placebo-controlled studies

A hypotensive effect of active vitamin D treatment (alphacalcidol 1 mg daily) has previously been reported in three double-blind, placebo-controlled studies over 4-6 months in subjects with mild primary hyperparathyroidism (HPT), intermittent hypercalcemia and essential hypertension. The commonly us...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Upsala journal of medical sciences 1991-01, Vol.96 (3), p.199-204
Hauptverfasser: Lind, L., Wengle, B., Lithell, H., Ljunghall, S.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 204
container_issue 3
container_start_page 199
container_title Upsala journal of medical sciences
container_volume 96
creator Lind, L.
Wengle, B.
Lithell, H.
Ljunghall, S.
description A hypotensive effect of active vitamin D treatment (alphacalcidol 1 mg daily) has previously been reported in three double-blind, placebo-controlled studies over 4-6 months in subjects with mild primary hyperparathyroidism (HPT), intermittent hypercalcemia and essential hypertension. The commonly used antihypertensive drugs, thiazides and betablockers, both induce impairments in both glucose and lipid metabolism and the thiazides are known to cause an elevation of serum urate. The effects of vitamin D treatment on these metabolic variables were recorded in these studies. Alphacalcidol did not induce any changes in fasting glucose HbA1c or insulin, serum triglycerides, cholesterol or serum urate in any of the treated groups. Neither was HDL cholesterol affected, except for a rise seen in the HPT subjects. It is therefore concluded that no major metabolic alterations in glucose or lipid metabolism or serum urate accompany the hypotensive effect of vitamin D.
doi_str_mv 10.3109/03009739109179271
format Article
fullrecord <record><control><sourceid>crossref_infor</sourceid><recordid>TN_cdi_crossref_primary_10_3109_03009739109179271</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3109_03009739109179271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c163t-4cb89c6d8c4d23b03b768ec166e37295e094171acb14880b7701b520d4ed7d033</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EEqHwAez8A4Fx7MaxxKYqhSK1sOCxjWzHFq6SOLItUP6eRGWHWM1ozj2zuAhdE7ihBMQtUADBqZh2wkXByQnKCgDIiSj5Kcpmnk8Bdo4uYjxMpAROM_T67PFeHnzAe5Ok8q3TeNUmE2Ryvo94pbXvBtmPOH0avB0Hn0wf3ZfBG2uNTtjbKZPmw4dLsnM9vr9EZ1a20Vz9zgV6f9i8rbf57uXxab3a5ZqUNOVMq0rosqk0awqqgCpeVmZipaG8EEsDghFOpFaEVRUozoGoZQENMw1vgNIFIse_OvgYg7H1EFwnw1gTqOdW6j-tTM7d0XG99aGT3z60TZ3k2Ppgg-y1i7P6n_4D4jJmuQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>No Major Metabolic Alterations Accompany the Hypotensive Effect of Active Vitamin D: Results from three double-blind, placebo-controlled studies</title><source>Taylor &amp; Francis:Master (3349 titles)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Lind, L. ; Wengle, B. ; Lithell, H. ; Ljunghall, S.</creator><creatorcontrib>Lind, L. ; Wengle, B. ; Lithell, H. ; Ljunghall, S.</creatorcontrib><description>A hypotensive effect of active vitamin D treatment (alphacalcidol 1 mg daily) has previously been reported in three double-blind, placebo-controlled studies over 4-6 months in subjects with mild primary hyperparathyroidism (HPT), intermittent hypercalcemia and essential hypertension. The commonly used antihypertensive drugs, thiazides and betablockers, both induce impairments in both glucose and lipid metabolism and the thiazides are known to cause an elevation of serum urate. The effects of vitamin D treatment on these metabolic variables were recorded in these studies. Alphacalcidol did not induce any changes in fasting glucose HbA1c or insulin, serum triglycerides, cholesterol or serum urate in any of the treated groups. Neither was HDL cholesterol affected, except for a rise seen in the HPT subjects. It is therefore concluded that no major metabolic alterations in glucose or lipid metabolism or serum urate accompany the hypotensive effect of vitamin D.</description><identifier>ISSN: 0300-9734</identifier><identifier>EISSN: 2000-1967</identifier><identifier>DOI: 10.3109/03009739109179271</identifier><language>eng</language><publisher>Taylor &amp; Francis</publisher><ispartof>Upsala journal of medical sciences, 1991-01, Vol.96 (3), p.199-204</ispartof><rights>1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1991</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c163t-4cb89c6d8c4d23b03b768ec166e37295e094171acb14880b7701b520d4ed7d033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/03009739109179271$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/03009739109179271$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,59647,60436</link.rule.ids></links><search><creatorcontrib>Lind, L.</creatorcontrib><creatorcontrib>Wengle, B.</creatorcontrib><creatorcontrib>Lithell, H.</creatorcontrib><creatorcontrib>Ljunghall, S.</creatorcontrib><title>No Major Metabolic Alterations Accompany the Hypotensive Effect of Active Vitamin D: Results from three double-blind, placebo-controlled studies</title><title>Upsala journal of medical sciences</title><description>A hypotensive effect of active vitamin D treatment (alphacalcidol 1 mg daily) has previously been reported in three double-blind, placebo-controlled studies over 4-6 months in subjects with mild primary hyperparathyroidism (HPT), intermittent hypercalcemia and essential hypertension. The commonly used antihypertensive drugs, thiazides and betablockers, both induce impairments in both glucose and lipid metabolism and the thiazides are known to cause an elevation of serum urate. The effects of vitamin D treatment on these metabolic variables were recorded in these studies. Alphacalcidol did not induce any changes in fasting glucose HbA1c or insulin, serum triglycerides, cholesterol or serum urate in any of the treated groups. Neither was HDL cholesterol affected, except for a rise seen in the HPT subjects. It is therefore concluded that no major metabolic alterations in glucose or lipid metabolism or serum urate accompany the hypotensive effect of vitamin D.</description><issn>0300-9734</issn><issn>2000-1967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNp1kMtOwzAQRS0EEqHwAez8A4Fx7MaxxKYqhSK1sOCxjWzHFq6SOLItUP6eRGWHWM1ozj2zuAhdE7ihBMQtUADBqZh2wkXByQnKCgDIiSj5Kcpmnk8Bdo4uYjxMpAROM_T67PFeHnzAe5Ok8q3TeNUmE2Ryvo94pbXvBtmPOH0avB0Hn0wf3ZfBG2uNTtjbKZPmw4dLsnM9vr9EZ1a20Vz9zgV6f9i8rbf57uXxab3a5ZqUNOVMq0rosqk0awqqgCpeVmZipaG8EEsDghFOpFaEVRUozoGoZQENMw1vgNIFIse_OvgYg7H1EFwnw1gTqOdW6j-tTM7d0XG99aGT3z60TZ3k2Ppgg-y1i7P6n_4D4jJmuQ</recordid><startdate>19910101</startdate><enddate>19910101</enddate><creator>Lind, L.</creator><creator>Wengle, B.</creator><creator>Lithell, H.</creator><creator>Ljunghall, S.</creator><general>Taylor &amp; Francis</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19910101</creationdate><title>No Major Metabolic Alterations Accompany the Hypotensive Effect of Active Vitamin D</title><author>Lind, L. ; Wengle, B. ; Lithell, H. ; Ljunghall, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c163t-4cb89c6d8c4d23b03b768ec166e37295e094171acb14880b7701b520d4ed7d033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lind, L.</creatorcontrib><creatorcontrib>Wengle, B.</creatorcontrib><creatorcontrib>Lithell, H.</creatorcontrib><creatorcontrib>Ljunghall, S.</creatorcontrib><collection>CrossRef</collection><jtitle>Upsala journal of medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lind, L.</au><au>Wengle, B.</au><au>Lithell, H.</au><au>Ljunghall, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No Major Metabolic Alterations Accompany the Hypotensive Effect of Active Vitamin D: Results from three double-blind, placebo-controlled studies</atitle><jtitle>Upsala journal of medical sciences</jtitle><date>1991-01-01</date><risdate>1991</risdate><volume>96</volume><issue>3</issue><spage>199</spage><epage>204</epage><pages>199-204</pages><issn>0300-9734</issn><eissn>2000-1967</eissn><abstract>A hypotensive effect of active vitamin D treatment (alphacalcidol 1 mg daily) has previously been reported in three double-blind, placebo-controlled studies over 4-6 months in subjects with mild primary hyperparathyroidism (HPT), intermittent hypercalcemia and essential hypertension. The commonly used antihypertensive drugs, thiazides and betablockers, both induce impairments in both glucose and lipid metabolism and the thiazides are known to cause an elevation of serum urate. The effects of vitamin D treatment on these metabolic variables were recorded in these studies. Alphacalcidol did not induce any changes in fasting glucose HbA1c or insulin, serum triglycerides, cholesterol or serum urate in any of the treated groups. Neither was HDL cholesterol affected, except for a rise seen in the HPT subjects. It is therefore concluded that no major metabolic alterations in glucose or lipid metabolism or serum urate accompany the hypotensive effect of vitamin D.</abstract><pub>Taylor &amp; Francis</pub><doi>10.3109/03009739109179271</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-9734
ispartof Upsala journal of medical sciences, 1991-01, Vol.96 (3), p.199-204
issn 0300-9734
2000-1967
language eng
recordid cdi_crossref_primary_10_3109_03009739109179271
source Taylor & Francis:Master (3349 titles); EZB-FREE-00999 freely available EZB journals
title No Major Metabolic Alterations Accompany the Hypotensive Effect of Active Vitamin D: Results from three double-blind, placebo-controlled studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A02%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20Major%20Metabolic%20Alterations%20Accompany%20the%20Hypotensive%20Effect%20of%20Active%20Vitamin%20D:%20Results%20from%20three%20double-blind,%20placebo-controlled%20studies&rft.jtitle=Upsala%20journal%20of%20medical%20sciences&rft.au=Lind,%20L.&rft.date=1991-01-01&rft.volume=96&rft.issue=3&rft.spage=199&rft.epage=204&rft.pages=199-204&rft.issn=0300-9734&rft.eissn=2000-1967&rft_id=info:doi/10.3109/03009739109179271&rft_dat=%3Ccrossref_infor%3E10_3109_03009739109179271%3C/crossref_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true